{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T21:43:05Z","timestamp":1780350185362,"version":"3.54.1"},"reference-count":201,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ccm.2024.04.002","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T22:56:40Z","timestamp":1722034600000},"page":"695-715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Innovations in Childhood Interstitial and Diffuse Lung Disease"],"prefix":"10.1016","volume":"45","author":[{"given":"Alicia","family":"Casey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth K.","family":"Fiorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Wambach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ccm.2024.04.002_bib1","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1164\/rccm.200703-393OC","article-title":"Diffuse lung disease in young children: application of a novel classification scheme","volume":"176","author":"Deutsch","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccm.2024.04.002_bib2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1164\/rccm.201305-0923ST","article-title":"An official american thoracic society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy","volume":"188","author":"Kurland","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2350\/08-11-0559.1","article-title":"Diffuse lung disease in infancy: a proposed classification applied to 259 diagnostic biopsies","volume":"12","author":"Langston","year":"2009","journal-title":"Pediatr Dev Pathol"},{"issue":"10","key":"10.1016\/j.ccm.2024.04.002_bib4","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1513\/AnnalsATS.201501-064OC","article-title":"Diffuse lung disease in biopsied children 2 to 18 years of age. Application of the child classification scheme","volume":"12","author":"Fan","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.ccm.2024.04.002_bib5","article-title":"The US national registry for childhood interstitial and diffuse lung disease: report of study design and initial enrollment cohort","author":"Nevel","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.ccm.2024.04.002_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ppul.20243","article-title":"Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia","volume":"40","author":"Deterding","year":"2005","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.ccm.2024.04.002_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ppul.1950322330","article-title":"Persistent tachypnea of infancy (pti)--a new entity","volume":"Suppl 23","author":"Deterding","year":"2001","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.ccm.2024.04.002_bib8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2214\/AJR.09.2743","article-title":"Neuroendocrine cell hyperplasia of infancy: diagnosis with high-resolution ct","volume":"194","author":"Brody","year":"2010","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"10.1016\/j.ccm.2024.04.002_bib9","first-page":"1730","article-title":"Rare becomes more common: recognizing neuroendocrine cell hyperplasia of infancy in everyday pulmonary consultations","volume":"12","author":"O'Connor","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"12","key":"10.1016\/j.ccm.2024.04.002_bib10","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00247-018-4189-6","article-title":"Lung and airway shape in neuroendocrine cell hyperplasia of infancy","volume":"48","author":"Mastej","year":"2018","journal-title":"Pediatr Radiol"},{"issue":"5","key":"10.1016\/j.ccm.2024.04.002_bib11","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1378\/chest.10-1304","article-title":"Neuroendocrine cell distribution and frequency distinguish neuroendocrine cell hyperplasia of infancy from other pulmonary disorders","volume":"139","author":"Young","year":"2011","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.ccm.2024.04.002_bib12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.devcel.2022.02.023","article-title":"Excess neuropeptides in lung signal through endothelial cells to impair gas exchange","volume":"57","author":"Xu","year":"2022","journal-title":"Dev Cell"},{"issue":"8","key":"10.1016\/j.ccm.2024.04.002_bib13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/thx.2008.107979","article-title":"Serum kl-6 differentiates neuroendocrine cell hyperplasia of infancy from the inborn errors of surfactant metabolism","volume":"64","author":"Doan","year":"2009","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.ccm.2024.04.002_bib14","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1164\/rccm.201903-0547OC","article-title":"Pulmonary aptamer signatures in children's interstitial and diffuse lung disease","volume":"200","author":"Deterding","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2024.04.002_bib15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/1750-1172-8-175","article-title":"Bronchoalveolar lavage fluid cytokine profiles in neuroendocrine cell hyperplasia of infancy and follicular bronchiolitis","volume":"8","author":"Popler","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.ccm.2024.04.002_bib16","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1378\/chest.13-0811","article-title":"A\u00a0mutation in ttf1\/nkx2.1 is associated with familial neuroendocrine cell hyperplasia of infancy","volume":"144","author":"Young","year":"2013","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ccm.2024.04.002_bib17","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/ppul.23958","article-title":"Growth trajectories and oxygen use in neuroendocrine cell hyperplasia of infancy","volume":"53","author":"Nevel","year":"2018","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib18","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1513\/AnnalsATS.201908-617OC","article-title":"Neuroendocrine cell hyperplasia of infancy. Clinical score and comorbidities","volume":"17","author":"Liptzin","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"10.1016\/j.ccm.2024.04.002_bib19","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1513\/AnnalsATS.201603-155BC","article-title":"Persistent lung disease in adults with nkx2.1 mutation and familial neuroendocrine cell hyperplasia of infancy","volume":"13","author":"Nevel","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"10.1016\/j.ccm.2024.04.002_bib20","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1164\/rccm.2105139","article-title":"Pulmonary interstitial glycogenosis: a new variant of neonatal interstitial lung disease","volume":"165","author":"Canakis","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.ccm.2024.04.002_bib21","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1002\/ppul.25548","article-title":"Pulmonary interstitial glycogenosis after the first year","volume":"56","author":"Liptzin","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"9","key":"10.1016\/j.ccm.2024.04.002_bib22","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00247-010-1730-7","article-title":"Pulmonary interstitial glycogenosis: Words of caution","volume":"40","author":"Deutsch","year":"2010","journal-title":"Pediatr Radiol"},{"issue":"9","key":"10.1016\/j.ccm.2024.04.002_bib23","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1007\/s00247-010-1670-2","article-title":"Pulmonary interstitial glycogenosis in the setting of lung growth abnormality: radiographic and pathologic correlation","volume":"40","author":"Castillo","year":"2010","journal-title":"Pediatr Radiol"},{"issue":"4","key":"10.1016\/j.ccm.2024.04.002_bib24","doi-asserted-by":"crossref","first-page":"2000853","DOI":"10.1183\/13993003.00853-2020","article-title":"Pulmonary interstitial glycogenosis cells express mesenchymal stem cell markers","volume":"56","author":"Galambos","year":"2020","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.ccm.2024.04.002_bib25","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/ppul.24123","article-title":"Pulmonary interstitial glycogenosis: diagnostic evaluation and clinical course","volume":"53","author":"Liptzin","year":"2018","journal-title":"Pediatr Pulmonol"},{"issue":"8","key":"10.1016\/j.ccm.2024.04.002_bib26","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s00247-018-4138-4","article-title":"High-resolution ct findings of pulmonary interstitial glycogenosis","volume":"48","author":"Weinman","year":"2018","journal-title":"Pediatr Radiol"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2350\/08-12-0575.1","article-title":"Histologic resolution of pulmonary interstitial glycogenosis","volume":"12","author":"Deutsch","year":"2009","journal-title":"Pediatr Dev Pathol"},{"issue":"5","key":"10.1016\/j.ccm.2024.04.002_bib28","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ppul.22871","article-title":"Pulmonary interstitial glycogenosis in a patient ultimately diagnosed with noonan syndrome","volume":"49","author":"Ross","year":"2014","journal-title":"Pediatr Pulmonol"},{"issue":"12","key":"10.1016\/j.ccm.2024.04.002_bib29","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1136\/annrheumdis-2019-216040","article-title":"Emergent high fatality lung disease in systemic juvenile arthritis","volume":"78","author":"Saper","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.ccm.2024.04.002_bib30","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1164\/rccm.202112-2742SO","article-title":"Autoimmune pulmonary alveolar proteinosis","volume":"205","author":"McCarthy","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.ccm.2024.04.002_bib31","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J\u00a0Clin Immunol"},{"issue":"1","key":"10.1016\/j.ccm.2024.04.002_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaip.2022.11.007","article-title":"Advances and challenges of the decade: the ever-changing clinical and genetic landscape of immunodeficiency","volume":"11","author":"Walter","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.ccm.2024.04.002_bib33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaci.2022.11.001","article-title":"Immune dysregulation","volume":"151","author":"Long","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.ccm.2024.04.002_bib34","doi-asserted-by":"crossref","first-page":"104501","DOI":"10.1016\/j.ebiom.2023.104501","article-title":"The link between rheumatic disorders and inborn errors of immunity","volume":"90","author":"Sogkas","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ccm.2024.04.002_bib35","doi-asserted-by":"crossref","first-page":"905109","DOI":"10.3389\/fimmu.2022.905109","article-title":"Dysregulation of the cgas-sting pathway in monogenic autoinflammation and lupus","volume":"13","author":"Wobma","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ccm.2024.04.002_bib36","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.rdc.2017.04.005","article-title":"Genomics of systemic lupus erythematosus: insights gained by studying monogenic young-onset systemic lupus erythematosus","volume":"43","author":"Hiraki","year":"2017","journal-title":"Rheum Dis Clin North Am"},{"issue":"19","key":"10.1016\/j.ccm.2024.04.002_bib37","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1056\/NEJMra1204664","article-title":"Obliterative bronchiolitis","volume":"370","author":"Barker","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ccm.2024.04.002_bib38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ppul.20145","article-title":"Bronchiolitis obliterans in children","volume":"39","author":"Kurland","year":"2005","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.ccm.2024.04.002_bib39","series-title":"Fishman's pulmonary diseases and disorders","article-title":"Bronchiolitis","author":"King","year":"1998"},{"key":"10.1016\/j.ccm.2024.04.002_bib40","doi-asserted-by":"crossref","first-page":"5852827","DOI":"10.1155\/2020\/5852827","article-title":"Postinfectious bronchiolitis obliterans in children: diagnostic workup and therapeutic options: a workshop report","volume":"2020","author":"Jerkic","year":"2020","journal-title":"Can Respir J"},{"key":"10.1016\/j.ccm.2024.04.002_bib41","first-page":"69","article-title":"Post-infectious bronchiolitis obliterans in children","volume":"42","author":"Flanagan","year":"2022","journal-title":"Paediatr Respir Rev"},{"issue":"2","key":"10.1016\/j.ccm.2024.04.002_bib42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/thoraxjnl-2014-205328","article-title":"Pulmonary function of a paediatric cohort of patients with postinfectious bronchiolitis obliterans. A long term follow-up","volume":"70","author":"Colom","year":"2015","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.ccm.2024.04.002_bib43","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MOP.0b013e3282ff62e9","article-title":"Bronchiolitis obliterans in children","volume":"20","author":"Moonnumakal","year":"2008","journal-title":"Curr Opin Pediatr"},{"issue":"9","key":"10.1016\/j.ccm.2024.04.002_bib44","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ppul.22929","article-title":"Exercise capacity in adolescent and adult patients with post infectious bronchiolitis obliterans","volume":"49","author":"Frohlich","year":"2014","journal-title":"Pediatr Pulmonol"},{"issue":"11","key":"10.1016\/j.ccm.2024.04.002_bib45","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/ppul.21080","article-title":"Clinical prediction rule to diagnose post-infectious bronchiolitis obliterans in children","volume":"44","author":"Colom","year":"2009","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.ccm.2024.04.002_bib46","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.prrv.2010.07.005","article-title":"Post infectious bronchiolitis obliterans in children","volume":"11","author":"Fischer","year":"2010","journal-title":"Paediatr Respir Rev"},{"issue":"1","key":"10.1016\/j.ccm.2024.04.002_bib47","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1164\/rccm.201708-1691IM","article-title":"Swyer-james syndrome","volume":"197","author":"Hamada","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2024.04.002_bib48","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13023-014-0128-2","article-title":"Follow-up on pediatric patients with bronchiolitis obliterans treated with corticosteroid pulse therapy","volume":"9","author":"Tomikawa","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"10.1016\/j.ccm.2024.04.002_bib49","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1002\/ppul.26577","article-title":"Successful treatment of postinfectious bronchiolitis obliterans with gamma globulin in a tertiary center: 10 years of experience","volume":"58","author":"Yilmaz","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.ccm.2024.04.002_bib50","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1378\/chest.12-2280","article-title":"Acute bronchodilator responsiveness to tiotropium in postinfectious bronchiolitis obliterans in children","volume":"144","author":"Teixeira","year":"2013","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2024.04.002_bib51","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(19)30256-X","article-title":"Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the european society for blood and marrow transplantation","volume":"7","author":"Penack","year":"2020","journal-title":"Lancet Haematol"},{"issue":"10","key":"10.1016\/j.ccm.2024.04.002_bib52","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/bmt.2010.311","article-title":"Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic sct: a case series of eight patients","volume":"46","author":"Norman","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.ccm.2024.04.002_bib53","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.bbmt.2015.10.009","article-title":"Fluticasone, azithromycin, and montelukast treatment for new-onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation","volume":"22","author":"Williams","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.ccm.2024.04.002_bib54","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jca.21404","article-title":"Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation","volume":"31","author":"Brownback","year":"2016","journal-title":"J\u00a0Clin Apher"},{"issue":"5","key":"10.1016\/j.ccm.2024.04.002_bib55","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/bmt.2015.324","article-title":"Extracorporeal photopheresis as a new supportive therapy for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation","volume":"51","author":"Del Fante","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.ccm.2024.04.002_bib56","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000431382","article-title":"Long-term off-line extracorporeal photochemotherapy in patients with chronic lung allograft rejection not responsive to conventional treatment: a 10-year single-centre analysis","volume":"90","author":"Del Fante","year":"2015","journal-title":"Respiration"},{"issue":"4","key":"10.1016\/j.ccm.2024.04.002_bib57","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/ajt.12155","article-title":"Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients","volume":"13","author":"Greer","year":"2013","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.ccm.2024.04.002_bib58","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.bbmt.2018.04.012","article-title":"Extracorporeal photopheresis improves survival in hematopoietic cell transplant patients with bronchiolitis obliterans syndrome without significantly impacting measured pulmonary functions","volume":"24","author":"Hefazi","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.ccm.2024.04.002_bib59","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.healun.2012.05.002","article-title":"A\u00a0prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation","volume":"31","author":"Jaksch","year":"2012","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.ccm.2024.04.002_bib60","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/bmt.2010.152","article-title":"Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-sct","volume":"46","author":"Lucid","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.ccm.2024.04.002_bib61","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.healun.2009.08.029","article-title":"The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation","volume":"29","author":"Morrell","year":"2010","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"17","key":"10.1016\/j.ccm.2024.04.002_bib62","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1182\/blood-2009-07-231159","article-title":"Limited efficacy of imatinib in severe pulmonary chronic graft-versus-host disease","volume":"114","author":"Stadler","year":"2009","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.ccm.2024.04.002_bib63","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/bmt.2015.120","article-title":"Imatinib for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation","volume":"50","author":"Watanabe","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.ccm.2024.04.002_bib64","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/s41409-019-0450-3","article-title":"Ruxolitinib is an effective steroid sparing agent in children with steroid refractory\/dependent bronchiolitis obliterans syndrome after allogenic hematopoietic cell transplantation","volume":"54","author":"Schoettler","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib65","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/s41409-019-0662-6","article-title":"Ruxolitinib is an effective steroid sparing agent in bronchiolitis obliterans due to chronic graft-versus-host-disease","volume":"55","author":"Streiler","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.ccm.2024.04.002_bib66","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2033122","article-title":"Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease","volume":"385","author":"Zeiser","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ccm.2024.04.002_bib67","doi-asserted-by":"crossref","first-page":"e0271979","DOI":"10.1371\/journal.pone.0271979","article-title":"Efficacy and safety of ruxolitinib for steroid-refractory graft-versus-host disease: systematic review and meta-analysis of randomised and non-randomised studies","volume":"17","author":"Zhang","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ccm.2024.04.002_bib68","doi-asserted-by":"crossref","first-page":"668825","DOI":"10.3389\/fphar.2021.668825","article-title":"Salvage therapy with low-dose ruxolitinib leads to a significant improvement in bronchiolitis obliterans syndrome in patients with cgvhd after allogeneic hematopoietic stem cell transplantation","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.ccm.2024.04.002_bib69","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1182\/blood.2022015598","article-title":"Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the rockstar study. Blood. 2021;138(22):2278-2289","volume":"139","author":"Cutler","year":"2022","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.ccm.2024.04.002_bib70","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1182\/bloodadvances.2023011820","article-title":"Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials. Blood adv. 2022;6(24):6263-6270","volume":"7","author":"Defilipp","year":"2023","journal-title":"Blood Adv"},{"issue":"17","key":"10.1016\/j.ccm.2024.04.002_bib71","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1200\/JCO.20.02754","article-title":"Rock2 inhibition with belumosudil (kd025) for the treatment of chronic graft-versus-host disease","volume":"39","author":"Jagasia","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"15","key":"10.1016\/j.ccm.2024.04.002_bib72","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1182\/bloodadvances.2022007773","article-title":"Organ-specific response after low-dose interleukin-2 therapy for steroid-refractory chronic graft-versus-host disease","volume":"6","author":"Kim","year":"2022","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.ccm.2024.04.002_bib73","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1182\/blood-2016-02-702852","article-title":"Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease","volume":"128","author":"Koreth","year":"2016","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.ccm.2024.04.002_bib74","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1182\/bloodadvances.2019000631","article-title":"Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children","volume":"3","author":"Whangbo","year":"2019","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.ccm.2024.04.002_bib75","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/ajt.12065","article-title":"Tnfalpha from classically activated macrophages accentuates epithelial to mesenchymal transition in obliterative bronchiolitis","volume":"13","author":"Borthwick","year":"2013","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.ccm.2024.04.002_bib76","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.bbmt.2011.11.031","article-title":"Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantation","volume":"18","author":"Yanik","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib77","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM199302113280606","article-title":"Brief report: deficiency of pulmonary surfactant protein b in congenital alveolar proteinosis","volume":"328","author":"Nogee","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.ccm.2024.04.002_bib78","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa032178","article-title":"Abca3 gene mutations in newborns with fatal surfactant deficiency","volume":"350","author":"Shulenin","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ccm.2024.04.002_bib79","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1056\/NEJM200102223440805","article-title":"A\u00a0mutation in the surfactant protein c gene associated with familial interstitial lung disease","volume":"344","author":"Nogee","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.ccm.2024.04.002_bib80","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/jamapediatrics.2021.3496","article-title":"Effect of whole-genome sequencing on the clinical management of acutely ill infants with suspected genetic disease: a randomized clinical trial","volume":"175","author":"Group","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"1","key":"10.1016\/j.ccm.2024.04.002_bib81","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s13023-022-02508-1","article-title":"The role of exome sequencing in childhood interstitial or diffuse lung disease","volume":"17","author":"Temple","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib82","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2105228119","article-title":"A\u00a0dominant negative variant of rab5b disrupts maturation of surfactant protein b and surfactant protein c","volume":"119","author":"Huang","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2\u20133","key":"10.1016\/j.ccm.2024.04.002_bib83","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0167-4889(89)90201-2","article-title":"In\u00a0vitro translation, post-translational processing and secretion of pulmonary surfactant protein b precursors","volume":"1011","author":"O'Reilly","year":"1989","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ccm.2024.04.002_bib84","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpeds.2017.01.017","article-title":"Outcomes of lung transplantation for infants and children with genetic disorders of surfactant metabolism","volume":"184","author":"Eldridge","year":"2017","journal-title":"J\u00a0Pediatr"},{"issue":"3 Pt 1","key":"10.1016\/j.ccm.2024.04.002_bib85","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1164\/ajrccm.161.3.9903153","article-title":"Allelic heterogeneity in hereditary surfactant protein b (sp-b) deficiency","volume":"161","author":"Nogee","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccm.2024.04.002_bib86","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2350\/09-01-0586.1","article-title":"Genetic disorders of surfactant dysfunction","volume":"12","author":"Wert","year":"2009","journal-title":"Pediatr Dev Pathol"},{"issue":"7809","key":"10.1016\/j.ccm.2024.04.002_bib87","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ccm.2024.04.002_bib88","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jpeds.2017.07.009","article-title":"Delayed presentation and prolonged survival of a child with surfactant protein b deficiency","volume":"190","author":"Lopez-Andreu","year":"2017","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.ccm.2024.04.002_bib89","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1203\/00006450-200009000-00003","article-title":"Prolonged survival in hereditary surfactant protein b (sp-b) deficiency associated with a novel splicing mutation","volume":"48","author":"Dunbar","year":"2000","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1016\/j.ccm.2024.04.002_bib90","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1165\/rcmb.2023-0156LE","article-title":"Homozygous, intragenic tandem duplication of sftpb causes neonatal respiratory failure","volume":"70","author":"Wambach","year":"2024","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"10.1016\/j.ccm.2024.04.002_bib91","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jpeds.2006.06.004","article-title":"Long-term outcomes after infant lung transplantation for surfactant protein b deficiency related to other causes of respiratory failure","volume":"149","author":"Palomar","year":"2006","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.ccm.2024.04.002_bib92","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1038\/s41467-020-17577-8","article-title":"A\u00a0lung tropic aav vector improves survival in a mouse model of surfactant b deficiency","volume":"11","author":"Kang","year":"2020","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib93","doi-asserted-by":"crossref","first-page":"101500","DOI":"10.1016\/j.siny.2023.101500","article-title":"Towards personalized therapies for genetic disorders of surfactant dysfunction","volume":"28","author":"Peers de Nieuwburgh","year":"2023","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.ccm.2024.04.002_bib94","doi-asserted-by":"crossref","first-page":"785829","DOI":"10.3389\/fgeed.2021.785829","article-title":"Gene therapy potential for genetic disorders of surfactant dysfunction","volume":"3","author":"Cooney","year":"2021","journal-title":"Front Genome"},{"issue":"19\u201320","key":"10.1016\/j.ccm.2024.04.002_bib95","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1089\/hum.2022.130","article-title":"Gene therapeutics for surfactant dysfunction disorders: targeting the alveolar type 2 epithelial cell","volume":"33","author":"Sitaraman","year":"2022","journal-title":"Hum Gene Ther"},{"issue":"35","key":"10.1016\/j.ccm.2024.04.002_bib96","doi-asserted-by":"crossref","first-page":"21986","DOI":"10.1016\/S0021-9258(18)45836-X","article-title":"Structure and expression of the pulmonary surfactant protein sp-c gene in the mouse","volume":"265","author":"Glasser","year":"1990","journal-title":"J\u00a0Biol Chem"},{"issue":"16","key":"10.1016\/j.ccm.2024.04.002_bib97","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1073\/pnas.87.16.6122","article-title":"Cis-acting sequences from a human surfactant protein gene confer pulmonary-specific gene expression in transgenic mice","volume":"87","author":"Korfhagen","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib98","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1165\/rcmb.2005-0009OC","article-title":"A\u00a0surfactant protein c precursor protein brichos domain mutation causes endoplasmic reticulum stress, proteasome dysfunction, and caspase 3 activation","volume":"32","author":"Mulugeta","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6 Pt 1","key":"10.1016\/j.ccm.2024.04.002_bib99","first-page":"L744","article-title":"Synthesis and processing of hydrophobic surfactant protein c by isolated rat type ii cells","volume":"269","author":"Beers","year":"1995","journal-title":"Am J Physiol"},{"issue":"32","key":"10.1016\/j.ccm.2024.04.002_bib100","doi-asserted-by":"crossref","first-page":"20318","DOI":"10.1016\/S0021-9258(17)31994-4","article-title":"Localization, synthesis, and processing of surfactant protein sp-c in rat lung analyzed by epitope-specific antipeptide antibodies","volume":"269","author":"Beers","year":"1994","journal-title":"J\u00a0Biol Chem"},{"issue":"11","key":"10.1016\/j.ccm.2024.04.002_bib101","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1073\/pnas.101500298","article-title":"Altered stability of pulmonary surfactant in sp-c-deficient mice","volume":"98","author":"Glasser","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.ccm.2024.04.002_bib102","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1164\/rccm.200112-123OC","article-title":"Heterozygosity for a surfactant protein c gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred","volume":"165","author":"Thomas","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2024.04.002_bib103","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1203\/PDR.0b013e3180a72588","article-title":"Heterozygosity for abca3 mutations modifies the severity of lung disease associated with a surfactant protein c gene (sftpc) mutation","volume":"62","author":"Bullard","year":"2007","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1016\/j.ccm.2024.04.002_bib104","doi-asserted-by":"crossref","first-page":"e000057","DOI":"10.1136\/bmjresp-2014-000057","article-title":"Sequencing of idiopathic pulmonary fibrosis-related genes reveals independent single gene associations","volume":"1","author":"Coghlan","year":"2014","journal-title":"BMJ Open Respir Res"},{"issue":"3","key":"10.1016\/j.ccm.2024.04.002_bib105","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1203\/PDR.0b013e3181eb5d68","article-title":"Surfactant protein-c promoter variants associated with neonatal respiratory distress syndrome reduce transcription","volume":"68","author":"Wambach","year":"2010","journal-title":"Pediatr Res"},{"issue":"2","key":"10.1016\/j.ccm.2024.04.002_bib106","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/BJ20080981","article-title":"Mutations linked to interstitial lung disease can abrogate anti-amyloid function of prosurfactant protein c","volume":"416","author":"Nerelius","year":"2008","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.ccm.2024.04.002_bib107","doi-asserted-by":"crossref","first-page":"L720","DOI":"10.1152\/ajplung.00025.2007","article-title":"Misfolded brichos sp-c mutant proteins induce apoptosis via caspase-4- and cytochrome c-related mechanisms","volume":"293","author":"Mulugeta","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib108","first-page":"e126125","article-title":"An sftpc brichos mutant links epithelial er stress and spontaneous lung fibrosis","volume":"4","author":"Katzen","year":"2019","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.ccm.2024.04.002_bib109","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1172\/JCI99287","article-title":"Expression of mutant sftpc in murine alveolar epithelia drives spontaneous lung fibrosis","volume":"128","author":"Nureki","year":"2018","journal-title":"J\u00a0Clin Invest"},{"issue":"9","key":"10.1016\/j.ccm.2024.04.002_bib110","doi-asserted-by":"crossref","first-page":"109636","DOI":"10.1016\/j.celrep.2021.109636","article-title":"Patient-specific ipscs carrying an sftpc mutation reveal the intrinsic alveolar epithelial dysfunction at the inception of interstitial lung disease","volume":"36","author":"Alysandratos","year":"2021","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib111","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/hmg\/ddy011","article-title":"Functional rescue of misfolding abca3 mutations by small molecular correctors","volume":"27","author":"Kinting","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.ccm.2024.04.002_bib112","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1111\/jcmm.14397","article-title":"Potentiation of abca3 lipid transport function by ivacaftor and genistein","volume":"23","author":"Kinting","year":"2019","journal-title":"J\u00a0Cell Mol Med"},{"issue":"12","key":"10.1016\/j.ccm.2024.04.002_bib113","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1164\/rccm.201402-0342OC","article-title":"Genotype-phenotype correlations for infants and children with abca3 deficiency","volume":"189","author":"Wambach","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccm.2024.04.002_bib114","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/MCP.0000000000000680","article-title":"Abca3 mutations in adult pulmonary fibrosis patients: a case series and review of literature","volume":"26","author":"Klay","year":"2020","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"10.1016\/j.ccm.2024.04.002_bib115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/thoraxjnl-2016-208649","article-title":"Lung disease caused by abca3 mutations","volume":"72","author":"Kroner","year":"2017","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.ccm.2024.04.002_bib116","doi-asserted-by":"crossref","first-page":"L291","DOI":"10.1152\/ajplung.00400.2020","article-title":"The common abca3(e292v) variant disrupts at2 cell quality control and increases susceptibility to lung injury and aberrant remodeling","volume":"321","author":"Tomer","year":"2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"25","key":"10.1016\/j.ccm.2024.04.002_bib117","doi-asserted-by":"crossref","first-page":"22147","DOI":"10.1074\/jbc.M201812200","article-title":"Identification of lbm180, a lamellar body limiting membrane protein of alveolar type ii cells, as the abc transporter protein abca3","volume":"277","author":"Mulugeta","year":"2002","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib118","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jpeds.2009.06.006","article-title":"Inherited surfactant deficiency caused by uniparental disomy of rare mutations in the surfactant protein-b and atp binding cassette, subfamily a, member 3 genes","volume":"155","author":"Hamvas","year":"2009","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib119","doi-asserted-by":"crossref","first-page":"e1575","DOI":"10.1542\/peds.2012-0918","article-title":"Single abca3 mutations increase risk for neonatal respiratory distress syndrome","volume":"130","author":"Wambach","year":"2012","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.ccm.2024.04.002_bib120","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1002\/ajmg.a.36660","article-title":"Single mutations in abca3 increase the risk for neonatal respiratory distress syndrome in late preterm infants (gestational age 34-36 weeks)","volume":"164A","author":"Naderi","year":"2014","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ccm.2024.04.002_bib121","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2119\/molmed.2015.00244","article-title":"Increased risk of interstitial lung disease in children with a single r288k variant of abca3","volume":"22","author":"Wittmann","year":"2016","journal-title":"Mol Med"},{"issue":"5","key":"10.1016\/j.ccm.2024.04.002_bib122","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1165\/rcmb.2016-0008OC","article-title":"Functional characterization of atp-binding cassette transporter a3 mutations from infants with respiratory distress syndrome","volume":"55","author":"Wambach","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"10.1016\/j.ccm.2024.04.002_bib123","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1165\/rcmb.2020-0034MA","article-title":"Functional genomics of abca3 variants","volume":"63","author":"Wambach","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"10.1016\/j.ccm.2024.04.002_bib124","doi-asserted-by":"crossref","first-page":"L698","DOI":"10.1152\/ajplung.90352.2008","article-title":"Aberrant catalytic cycle and impaired lipid transport into intracellular vesicles in abca3 mutants associated with nonfatal pediatric interstitial lung disease","volume":"295","author":"Matsumura","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"45","key":"10.1016\/j.ccm.2024.04.002_bib125","doi-asserted-by":"crossref","first-page":"34503","DOI":"10.1074\/jbc.M600071200","article-title":"Characterization and classification of atp-binding cassette transporter abca3 mutants in fatal surfactant deficiency","volume":"281","author":"Matsumura","year":"2006","journal-title":"J\u00a0Biol Chem"},{"issue":"17","key":"10.1016\/j.ccm.2024.04.002_bib126","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1016\/j.febslet.2007.05.078","article-title":"Abca3-mediated choline-phospholipids uptake into intracellular vesicles in a549 cells","volume":"581","author":"Matsumura","year":"2007","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1016\/j.ccm.2024.04.002_bib127","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1006\/dbio.1995.8080","article-title":"Ttf-1 regulates lung epithelial morphogenesis","volume":"172","author":"Minoo","year":"1995","journal-title":"Dev Biol"},{"issue":"1","key":"10.1016\/j.ccm.2024.04.002_bib128","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1101\/gad.10.1.60","article-title":"The t\/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary","volume":"10","author":"Kimura","year":"1996","journal-title":"Genes Dev"},{"issue":"3","key":"10.1016\/j.ccm.2024.04.002_bib129","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1378\/chest.12-2502","article-title":"Heterogeneous pulmonary phenotypes associated with mutations in the thyroid transcription factor gene nkx2-1","volume":"144","author":"Hamvas","year":"2013","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ccm.2024.04.002_bib130","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1172\/JCI0214341","article-title":"Choreoathetosis, hypothyroidism, and pulmonary alterations due to human nkx2-1 haploinsufficiency","volume":"109","author":"Krude","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib131","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/jmedgenet-2013-102248","article-title":"Comprehensive genotyping and clinical characterisation reveal 27 novel nkx2-1 mutations and expand the phenotypic spectrum","volume":"51","author":"Thorwarth","year":"2014","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.ccm.2024.04.002_bib132","series-title":"Nkx2-1-related disorders","author":"Patel","year":"1993"},{"issue":"5","key":"10.1016\/j.ccm.2024.04.002_bib133","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/ajcp\/76.5.722","article-title":"Congenital alveolar capillary dysplasia--an unusual cause of respiratory distress in the newborn","volume":"76","author":"Janney","year":"1981","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib134","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/humu.22313","article-title":"Novel foxf1 mutations in sporadic and familial cases of alveolar capillary dysplasia with misaligned pulmonary veins imply a role for its DNA binding domain","volume":"34","author":"Sen","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ccm.2024.04.002_bib135","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jpeds.2017.10.026","article-title":"Infants with atypical presentations of alveolar capillary dysplasia with misalignment of the pulmonary veins who underwent bilateral lung transplantation","volume":"194","author":"Towe","year":"2018","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ccm.2024.04.002_bib136","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jpeds.2019.01.047","article-title":"Histopathologic and genetic features of alveolar capillary dysplasia with atypical late presentation and prolonged survival","volume":"210","author":"Edwards","year":"2019","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.ccm.2024.04.002_bib137","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1164\/rccm.201010-1697CI","article-title":"Alveolar capillary dysplasia","volume":"184","author":"Bishop","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccm.2024.04.002_bib138","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jpeds.2004.06.081","article-title":"Expanding the phenotype of alveolar capillary dysplasia (acd)","volume":"145","author":"Sen","year":"2004","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.ccm.2024.04.002_bib139","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/15513819109064753","article-title":"Misalignment of pulmonary veins and alveolar capillary dysplasia","volume":"11","author":"Langston","year":"1991","journal-title":"Pediatr Pathol"},{"issue":"1","key":"10.1016\/j.ccm.2024.04.002_bib140","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jpeds.2013.08.035","article-title":"Three-dimensional reconstruction identifies misaligned pulmonary veins as intrapulmonary shunt vessels in alveolar capillary dysplasia","volume":"164","author":"Galambos","year":"2014","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib141","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ajhg.2009.05.005","article-title":"Genomic and genic deletions of the fox gene cluster on 16q24.1 and inactivating mutations of foxf1 cause alveolar capillary dysplasia and other malformations","volume":"84","author":"Stankiewicz","year":"2009","journal-title":"Am J Hum Genet"},{"issue":"8","key":"10.1016\/j.ccm.2024.04.002_bib142","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1164\/rccm.202207-1332OC","article-title":"Novel foxf1-stabilizing compound tanfe stimulates lung angiogenesis in alveolar capillary dysplasia","volume":"207","author":"Pradhan","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib143","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ng.3279","article-title":"Copa mutations impair er-golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis","volume":"47","author":"Watkin","year":"2015","journal-title":"Nat Genet"},{"issue":"13","key":"10.1016\/j.ccm.2024.04.002_bib144","doi-asserted-by":"crossref","first-page":"9628","DOI":"10.1074\/jbc.M611767200","article-title":"Abca3 as a lipid transporter in pulmonary surfactant biogenesis","volume":"282","author":"Ban","year":"2007","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.ccm.2024.04.002_bib145","doi-asserted-by":"crossref","first-page":"105070","DOI":"10.1016\/j.jbspin.2020.09.002","article-title":"Copa syndrome, 5 years after: where are we?","volume":"88","author":"Fremond","year":"2021","journal-title":"Joint Bone Spine"},{"issue":"12","key":"10.1016\/j.ccm.2024.04.002_bib146","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1172\/JCI79100","article-title":"Inherited sting-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations","volume":"124","author":"Jeremiah","year":"2014","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.ccm.2024.04.002_bib147","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10875-021-00974-z","article-title":"Sting-mediated lung inflammation and beyond","volume":"41","author":"Fremond","year":"2021","journal-title":"J\u00a0Clin Immunol"},{"issue":"2","key":"10.1016\/j.ccm.2024.04.002_bib148","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jaip.2020.11.007","article-title":"Overview of sting-associated vasculopathy with onset in infancy (savi) among 21 patients","volume":"9","author":"Fremond","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.ccm.2024.04.002_bib149","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3389\/fped.2020.00543","article-title":"Familial interstitial lung disease caused by mutation of the sting1 gene","volume":"8","author":"Li","year":"2020","journal-title":"Front Pediatr"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib150","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1312625","article-title":"Activated sting in a vascular and pulmonary syndrome","volume":"371","author":"Liu","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib151","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/cge.13943","article-title":"Fars1-related disorders caused by bi-allelic mutations in cytosolic phenylalanyl-trna synthetase genes: look beyond the lungs","volume":"99","author":"Schuch","year":"2021","journal-title":"Clin Genet"},{"issue":"10","key":"10.1016\/j.ccm.2024.04.002_bib152","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/humu.23595","article-title":"Homozygosity for farsb mutation leads to phe-trna synthetase-related disease of growth restriction, brain calcification, and interstitial lung disease","volume":"39","author":"Zadjali","year":"2018","journal-title":"Hum Mutat"},{"issue":"11","key":"10.1016\/j.ccm.2024.04.002_bib153","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1002\/ppul.25031","article-title":"Rescue of respiratory failure in pulmonary alveolar proteinosis due to pathogenic mars1 variants","volume":"55","author":"Lenz","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"10","key":"10.1016\/j.ccm.2024.04.002_bib154","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ejmg.2018.04.005","article-title":"Mars variant associated with both recessive interstitial lung and liver disease and dominant charcot-marie-tooth disease","volume":"61","author":"Rips","year":"2018","journal-title":"Eur J Med Genet"},{"issue":"11","key":"10.1016\/j.ccm.2024.04.002_bib155","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1002\/ppul.26083","article-title":"Building a pediatric rare lung disease program: it takes a community of villages","volume":"57","author":"Vece","year":"2022","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.ccm.2024.04.002_bib156","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/lary.27939","article-title":"Demonstrating the benefits of a multidisciplinary aerodigestive program","volume":"130","author":"Ruiz","year":"2020","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ccm.2024.04.002_bib157","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2147\/PPA.S130439","article-title":"Strengthening care teams to improve adherence in cystic fibrosis: a qualitative practice assessment and quality improvement initiative","volume":"11","author":"Gardner","year":"2017","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"10.1016\/j.ccm.2024.04.002_bib158","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ppul.23304","article-title":"Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: pcd foundation consensus recommendations based on state of the art review","volume":"51","author":"Shapiro","year":"2016","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"10.1016\/j.ccm.2024.04.002_bib159","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1172\/JCI98814","article-title":"Jak1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies","volume":"128","author":"Sanchez","year":"2018","journal-title":"J\u00a0Clin Invest"},{"issue":"Suppl1","key":"10.1016\/j.ccm.2024.04.002_bib160","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.5152\/eurjrheum.2019.18177","article-title":"Baricitinib in therapy of copa syndrome in a 15-year-old girl","volume":"7","author":"Krutzke","year":"2020","journal-title":"Eur J Rheumatol"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib161","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jaci.2016.07.015","article-title":"Efficacy of the janus kinase 1\/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with tmem173-activating mutations in 3 children","volume":"138","author":"Fremond","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib162","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.chest.2016.03.020","article-title":"Response","volume":"149","author":"Young","year":"2016","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib163","doi-asserted-by":"crossref","first-page":"e20152725","DOI":"10.1542\/peds.2015-2725","article-title":"Interstitial lung disease in children younger than 2 years","volume":"137","author":"Spagnolo","year":"2016","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.ccm.2024.04.002_bib164","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/thoraxjnl-2015-207508","article-title":"Look back with (some) anger, and a lot of pleasure","volume":"70","author":"Bush","year":"2015","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.ccm.2024.04.002_bib165","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/ped.2010.0005","article-title":"Child family education","volume":"23","author":"McDougal","year":"2010","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"issue":"3","key":"10.1016\/j.ccm.2024.04.002_bib166","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MOP.0b013e3283464a37","article-title":"Interstitial lung disease in children","volume":"23","author":"Das","year":"2011","journal-title":"Curr Opin Pediatr"},{"issue":"4","key":"10.1016\/j.ccm.2024.04.002_bib167","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.prrv.2011.04.001","article-title":"Diagnosis and management of diffuse lung disease in children","volume":"12","author":"Vece","year":"2011","journal-title":"Paediatr Respir Rev"},{"issue":"7","key":"10.1016\/j.ccm.2024.04.002_bib168","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1513\/AnnalsATS.201902-136CME","article-title":"2019 Clinical practice guideline summary for clinicians: home oxygen therapy for children","volume":"16","author":"Krivchenia","year":"2019","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"10.1016\/j.ccm.2024.04.002_bib169","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/thoraxjnl-2021-217941","article-title":"Acute exacerbations in children's interstitial lung disease","volume":"77","author":"Seidl","year":"2022","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.ccm.2024.04.002_bib170","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1165\/rcmb.2021-0223OC","article-title":"High-content screening identifies cyclosporin a as a novel abca3-specific molecular corrector","volume":"66","author":"Forstner","year":"2022","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"10.1016\/j.ccm.2024.04.002_bib171","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/ppul.26722","article-title":"Noninvasive management of infants with sftpc pathogenic variants","volume":"59","author":"Liptzin","year":"2024","journal-title":"Pediatr Pulmonol"},{"issue":"11","key":"10.1016\/j.ccm.2024.04.002_bib172","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1164\/rccm.201411-1955LE","article-title":"Chronic ventilation in infants with surfactant protein c mutations: an alternative to lung transplantation","volume":"191","author":"Liptzin","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib173","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/thoraxjnl-2021-217361","article-title":"Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study","volume":"77","author":"Guler","year":"2022","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.ccm.2024.04.002_bib174","doi-asserted-by":"crossref","first-page":"2201512","DOI":"10.1183\/13993003.01512-2022","article-title":"Nintedanib in children and adolescents with fibrosing interstitial lung diseases","volume":"61","author":"Deterding","year":"2022","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.ccm.2024.04.002_bib175","doi-asserted-by":"crossref","first-page":"2251512","DOI":"10.1183\/13993003.01512-2022","article-title":"Nintedanib in children and adolescents with fibrosing interstitial lung diseases","volume":"61","author":"Deterding","year":"2023","journal-title":"Eur Respir J"},{"issue":"22","key":"10.1016\/j.ccm.2024.04.002_bib176","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.ccm.2024.04.002_bib177","first-page":"1596","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease. Reply","volume":"381","author":"Distler","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.ccm.2024.04.002_bib178","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ccm.2024.04.002_bib179","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/ppul.25924","article-title":"Genetic diagnosis of immune dysregulation can lead to targeted therapy for interstitial lung disease: a case series and single center approach","volume":"57","author":"Wobma","year":"2022","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib180","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.rcl.2022.06.008","article-title":"Advances in imaging of the child - childhood interstitial lung disease","volume":"60","author":"DiPrete","year":"2022","journal-title":"Radiol Clin North Am"},{"issue":"4","key":"10.1016\/j.ccm.2024.04.002_bib181","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ppul.26857","article-title":"Imaging of pulmonary fibrosis in children: a review, with proposed diagnostic criteria","volume":"59","author":"DeBoer","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.ccm.2024.04.002_bib182","article-title":"Advancements in imaging in child","author":"Spielberg","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.ccm.2024.04.002_bib183","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/ped.2010.0010","article-title":"Imaging of childhood interstitial lung disease","volume":"23","author":"Guillerman","year":"2010","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"issue":"1","key":"10.1016\/j.ccm.2024.04.002_bib184","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.rcl.2021.08.009","article-title":"Childhood interstitial lung disease: imaging guidelines and recommendations","volume":"60","author":"Semple","year":"2022","journal-title":"Radiol Clin North Am"},{"issue":"5","key":"10.1016\/j.ccm.2024.04.002_bib185","doi-asserted-by":"crossref","first-page":"958","DOI":"10.2214\/AJR.18.20696","article-title":"Childhood interstitial (diffuse) lung disease: pattern recognition approach to diagnosis in infants","volume":"212","author":"Liang","year":"2019","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib186","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/ppul.25319","article-title":"Clinical, functional, and computed tomography findings in a cohort of patients with neuroendocrine cell hyperplasia of infancy","volume":"56","author":"Balinotti","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.ccm.2024.04.002_bib187","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.acra.2017.09.013","article-title":"Diagnostic utility of 3t lung mri in children with interstitial lung disease: a prospective pilot study","volume":"25","author":"Sodhi","year":"2018","journal-title":"Acad Radiol"},{"issue":"3","key":"10.1016\/j.ccm.2024.04.002_bib188","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.acra.2018.12.007","article-title":"Structure-function imaging of lung disease using ultrashort echo time mri","volume":"26","author":"Torres","year":"2019","journal-title":"Acad Radiol"},{"issue":"2","key":"10.1016\/j.ccm.2024.04.002_bib189","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcf.2016.07.008","article-title":"Hyperpolarized (129)xe for investigation of mild cystic fibrosis lung disease in pediatric patients","volume":"16","author":"Thomen","year":"2017","journal-title":"J\u00a0Cyst Fibros"},{"issue":"5","key":"10.1016\/j.ccm.2024.04.002_bib190","doi-asserted-by":"crossref","first-page":"1801779","DOI":"10.1183\/13993003.01779-2018","article-title":"Xenon-129 mri detects ventilation deficits in paediatric stem cell transplant patients unable to perform spirometry","volume":"53","author":"Walkup","year":"2019","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.ccm.2024.04.002_bib191","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1164\/rccm.202103-0736LE","article-title":"Modern lung magnetic resonance imaging to screen for pulmonary complications in patients with dyskeratosis congenita","volume":"204","author":"Walkup","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 2","key":"10.1016\/j.ccm.2024.04.002_bib192","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1016\/j.acra.2021.06.017","article-title":"Hyperpolarized (129)xenon mri ventilation defect quantification via thresholding and linear binning in multiple pulmonary diseases","volume":"29","author":"Roach","year":"2022","journal-title":"Acad Radiol"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib193","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/jmri.27487","article-title":"Effects of neonatal lung abnormalities on parenchymal r(2) \u2217 estimates","volume":"53","author":"Hahn","year":"2021","journal-title":"J\u00a0Magn Reson Imaging"},{"issue":"1","key":"10.1016\/j.ccm.2024.04.002_bib194","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41467-020-14348-3","article-title":"The in\u00a0vivo genetic program of murine primordial lung epithelial progenitors","volume":"11","author":"Ikonomou","year":"2020","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.ccm.2024.04.002_bib195","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cell.2023.11.036","article-title":"Human inherited ccr2 deficiency underlies progressive polycystic lung disease","volume":"187","author":"Neehus","year":"2024","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ccm.2024.04.002_bib196","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/thorax-2022-219434","article-title":"Abca3-related interstitial lung disease beyond infancy","volume":"78","author":"Li","year":"2023","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.ccm.2024.04.002_bib197","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/ppul.24018","article-title":"Development and validation of a health-related quality of life questionnaire for pediatric patients with interstitial lung disease","volume":"53","author":"Niemitz","year":"2018","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.ccm.2024.04.002_bib198","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13023-022-02399-2","article-title":"Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung disease","volume":"17","author":"Griese","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"10.1016\/j.ccm.2024.04.002_bib199","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/thoraxjnl-2021-217751","article-title":"Healthcare resource utilisation and medical costs for children with interstitial lung diseases (child) in europe","volume":"77","author":"Seidl","year":"2022","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.ccm.2024.04.002_bib200","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13023-017-0637-x","article-title":"Childhood interstitial lung diseases in immunocompetent children in Australia and New Zealand: a decade's experience","volume":"12","author":"Saddi","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.ccm.2024.04.002_bib201","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00431-023-05290-9","article-title":"Childhood interstitial lung disease in Turkey: first data from the national registry","volume":"183","author":"Nayir-Buyuksahin","year":"2024","journal-title":"Eur J Pediatr"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523124000492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523124000492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T23:13:16Z","timestamp":1728515596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523124000492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":201,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0272523124000492"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2024.04.002","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innovations in Childhood Interstitial and Diffuse Lung Disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2024.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}